Tag
Shilpa Divekar Nirula
2 articles
AstraZeneca India FY26 Revenue Up 33% to ₹22.8B
AstraZeneca Pharma India reported 33% YoY revenue growth to ₹22,755.8 million for FY26 with net profit of ₹1,875.2 million.
Board recommended final dividend of ₹36 per share and approved reappointment
AstraZeneca India FY26 Revenue Up 33% to ₹22.8B
AstraZeneca India reported FY26 audited results with 33% revenue growth to ₹22.8B and PAT of ₹1.9B, recommending ₹36/share dividend.
Board approved reappointment of Shilpa Divekar Nirula as Independen